An epitranscriptomic vulnerability in myeloid malignancies
Nature Medicine 23, 1252 (2017).
doi:10.1038/nm.4435
Authors: Alexandra C Schmiechen & Pedro J Batista
A recent study finds that the N6-methyladenosine (m6A) modifier METTL3 regulates proliferation and differentiation in myeloid cells and acute myeloid leukemia (AML).
Source: Nature Medicine - Category: General Medicine Authors: Alexandra C Schmiechen Pedro J Batista Tags: News and Views Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | General Medicine | Leukemia | Study